AnthonyDerekSungMD

Hematology • Westwood, KS

Hematologic Oncology

Medical Instructor, Hematologic Malignancies and Cellular Therapy, Duke University Medical Center

Join to view full profile

Dr. Sung is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sung's full profile

Already have an account?

Office
2650 Shawnee Mission Pkwy
Westwood, KS 66205
Phone+1 913-945-6674

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 2011 - 2014
Johns Hopkins UniversityInternship, Internal Medicine, 2008 - 2011
Harvard Medical SchoolClass of 2008

Certifications & Licensure

MO State Medical License 2024 - 2026
KS State Medical License 2024 - 2025
NC State Medical License 2014 - 2025
American Board of Internal Medicine Hematology

Clinical Trials

MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Start of enrollment: 2021 Sep 01
Withdrawn
Phase 1, Phase 2
ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant (HCT) Patients Start of enrollment: 2020 Oct 14
Active, not recruiting
Not Applicable
Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2 Start of enrollment: 2014 Sep 03
Terminated
Not Applicable
Roles: Sub-Investigator, Contact
A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation Start of enrollment: 2018 Sep 28
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Testing a Device for Automatically TRacking Urine and STool in an Inpatient HCT Setting (Project TRUST) Start of enrollment: 2023 Sep 13
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Cutaneous dysbiosis characterizes the post-allogeneic hematopoietic stem cell transplantation period.
Adela R Cardones, Akintunde Emiola, Russell Hall, Anthony D Sung, Jennifer Y Zhang
Blood Advances. 2025-01-24
Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantation.
Ashley L Artese, Michele Sainvil, Laura J Fish, Lauren Hill, Tamara Somers
Supportive Care in Cancer. 2024-11-28
Ibrutinib for therapy of steroid-refractory chronic graft vs. host disease: A multicenter real-world analysis.
Joseph A Pidala, Jongphil Kim, Denise Kalos, Corey S Cutler, Zachariah DeFilipp
Blood Advances. 2024-10-25

Press Mentions

KU-Led Multicenter Trial to Address Food Insecurity and Malnutrition in Cancer PatientsJanuary 13th, 2025
More Options for People with Blood CancersMay 10th, 2023
FDA Panel Says Poziotinib’s Benefits Don’t Outweigh Risks in NSCLC With HER2 Exon 20 MutationsSeptember 22nd, 2022
Join now to see all